Walleye Capital’s National Healthcare NHC Stock Holding History

Walleye Capital’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-476	Closed	-$41K	–	1422
2019 Q4	$41K	Buy	+476	New	+$39.8K	﹤0.01%	1535

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MHS

M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Walleye Capital's NHC Position: Q1 2020 in Review

Walleye Capital sold out of National Healthcare (NHC) in Q1 2020, closing a stake of 476 shares — an estimated $41K sold.

Walleye Capital first reported a position in NHC in Q4 2019 and held it in 1 quarter. The position peaked at $41K in Q4 2019. 147 funds tracked by Wall St. Rank hold NHC as of Q1 2020.

Walleye Capital reported no remaining National Healthcare position as of Q1 2020 after selling out during the quarter.
Walleye Capital sold 476 National Healthcare shares in Q1 2020, an estimated $41K.
Walleye Capital first reported a position in National Healthcare in Q4 2019 and held it in 1 quarter.
Walleye Capital's National Healthcare position peaked at $41K in Q4 2019.
147 funds tracked by Wall St. Rank held National Healthcare as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.